Our History
2014
The company was established with the name Altermune Limited.
2015
Laboratories at Discovery Park, Kent were established and the name change adopted. Staff numbers soon grew to fifteen and research using Alphamer technology started.
2016
Centauri established a joint venture company, Avvinity Therapeutics, with Horizon Discovery to undertake oncology research using the Alphamer technology.
2018
Centauri was awarded an Innovate UK grant for £1.3m to undertake anti-infectives research using the Alphamer technology
2019
Centauri was awarded a CARB-X grant for $1.4m to undertake anti-infectives research using the Alphamer technology
2022
Centauri moved its laboratory to Alderley Park, Cheshire and has been awarded a second CARB-X grant for $2.7m to undertake anti-infectives research using the Alphamer technology.